ALTIMMUNE INC (ALT) Fundamental Analysis & Valuation

NASDAQ:ALT • US02155H2004

Current stock price

3.34 USD
+0.22 (+7.05%)
At close:
3.34 USD
0 (0%)
After Hours:

This ALT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALT Profitability Analysis

1.1 Basic Checks

  • In the past year ALT has reported negative net income.
  • In the past year ALT has reported a negative cash flow from operations.
  • ALT had negative earnings in each of the past 5 years.
  • In the past 5 years ALT always reported negative operating cash flow.
ALT Yearly Net Income VS EBIT VS OCF VS FCFALT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • The Return On Assets of ALT (-31.47%) is better than 63.64% of its industry peers.
  • ALT has a Return On Equity of -39.17%. This is in the better half of the industry: ALT outperforms 69.83% of its industry peers.
Industry RankSector Rank
ROA -31.47%
ROE -39.17%
ROIC N/A
ROA(3y)-47.23%
ROA(5y)-45.4%
ROE(3y)-53.9%
ROE(5y)-51.24%
ROIC(3y)N/A
ROIC(5y)N/A
ALT Yearly ROA, ROE, ROICALT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ALT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALT Yearly Profit, Operating, Gross MarginsALT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200K -400K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALT Health Analysis

2.1 Basic Checks

  • ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALT has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALT has more shares outstanding
  • Compared to 1 year ago, ALT has a worse debt to assets ratio.
ALT Yearly Shares OutstandingALT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALT Yearly Total Debt VS Total AssetsALT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of 1.19, we must say that ALT is in the distress zone and has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.19, ALT is doing good in the industry, outperforming 62.48% of the companies in the same industry.
  • A Debt/Equity ratio of 0.15 indicates that ALT is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.15, ALT is not doing good in the industry: 64.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACCN/A
WACC9.25%
ALT Yearly LT Debt VS Equity VS FCFALT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 18.55 indicates that ALT has no problem at all paying its short term obligations.
  • ALT's Current ratio of 18.55 is amongst the best of the industry. ALT outperforms 94.97% of its industry peers.
  • ALT has a Quick Ratio of 18.55. This indicates that ALT is financially healthy and has no problem in meeting its short term obligations.
  • ALT has a Quick ratio of 18.55. This is amongst the best in the industry. ALT outperforms 94.97% of its industry peers.
Industry RankSector Rank
Current Ratio 18.55
Quick Ratio 18.55
ALT Yearly Current Assets VS Current LiabilitesALT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALT Growth Analysis

3.1 Past

  • ALT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.63%, which is quite impressive.
  • The Revenue has grown by 105.00% in the past year. This is a very strong growth!
  • Measured over the past years, ALT shows a very negative growth in Revenue. The Revenue has been decreasing by -65.33% on average per year.
EPS 1Y (TTM)24.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)105%
Revenue growth 3YN/A
Revenue growth 5Y-65.33%
Sales Q2Q%420%

3.2 Future

  • Based on estimates for the next years, ALT will show a very strong growth in Earnings Per Share. The EPS will grow by 51.66% on average per year.
  • The Revenue is expected to grow by 824.40% on average over the next years. This is a very strong growth
EPS Next Y-23.08%
EPS Next 2Y-4.96%
EPS Next 3Y70.96%
EPS Next 5Y51.66%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y2296.44%
Revenue Next 5Y824.4%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALT Yearly Revenue VS EstimatesALT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2028 2029 2030 2031 2032 2033 0 500M 1B 1.5B
ALT Yearly EPS VS EstimatesALT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALT Valuation Analysis

4.1 Price/Earnings Ratio

  • ALT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALT Price Earnings VS Forward Price EarningsALT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALT Per share dataALT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALT's earnings are expected to grow with 70.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.96%
EPS Next 3Y70.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALT Dividend Analysis

5.1 Amount

  • ALT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALT Fundamentals: All Metrics, Ratios and Statistics

ALTIMMUNE INC

NASDAQ:ALT (4/2/2026, 5:26:13 PM)

After market: 3.34 0 (0%)

3.34

+0.22 (+7.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-05
Earnings (Next)05-11
Inst Owners49.01%
Inst Owner Change21.03%
Ins Owners0.7%
Ins Owner Change3.92%
Market Cap434.43M
Revenue(TTM)41.00K
Net Income(TTM)-88.09M
Analysts78.67
Price Target19.58 (486.23%)
Short Float %20.5%
Short Ratio6.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.99%
Min EPS beat(2)-10.16%
Max EPS beat(2)26.14%
EPS beat(4)3
Avg EPS beat(4)15.58%
Min EPS beat(4)-10.16%
Max EPS beat(4)29.11%
EPS beat(8)6
Avg EPS beat(8)9.96%
EPS beat(12)10
Avg EPS beat(12)13.55%
EPS beat(16)14
Avg EPS beat(16)13.85%
Revenue beat(2)2
Avg Revenue beat(2)1910.88%
Min Revenue beat(2)296.04%
Max Revenue beat(2)3525.71%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.92%
PT rev (3m)4.1%
EPS NQ rev (1m)7.13%
EPS NQ rev (3m)7.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)-14.46%
Revenue NQ rev (3m)-29%
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10595.95
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB 1.93
EV/EBITDA N/A
EPS(TTM)-1.01
EYN/A
EPS(NY)-1.24
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.47%
ROE -39.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.23%
ROA(5y)-45.4%
ROE(3y)-53.9%
ROE(5y)-51.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.82%
Cap/Sales 26.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 18.55
Quick Ratio 18.55
Altman-Z 1.19
F-Score5
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y-23.08%
EPS Next 2Y-4.96%
EPS Next 3Y70.96%
EPS Next 5Y51.66%
Revenue 1Y (TTM)105%
Revenue growth 3YN/A
Revenue growth 5Y-65.33%
Sales Q2Q%420%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y2296.44%
Revenue Next 5Y824.4%
EBIT growth 1Y8.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-43.11%
EBIT Next 3Y4.13%
EBIT Next 5Y26.2%
FCF growth 1Y15.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.42%
OCF growth 3YN/A
OCF growth 5YN/A

ALTIMMUNE INC / ALT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALTIMMUNE INC (ALT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALT.


What is the valuation status for ALT stock?

ChartMill assigns a valuation rating of 1 / 10 to ALTIMMUNE INC (ALT). This can be considered as Overvalued.


What is the profitability of ALT stock?

ALTIMMUNE INC (ALT) has a profitability rating of 1 / 10.


What is the expected EPS growth for ALTIMMUNE INC (ALT) stock?

The Earnings per Share (EPS) of ALTIMMUNE INC (ALT) is expected to decline by -23.08% in the next year.